While the experimental drug met its key targets, analysts are concerned over the commercial opportunity due to side effects.
Weight loss drug maker sinks 25% after new safety data spooks investors
While the experimental drug met its key targets, analysts are concerned over the commercial opportunity due to side effects.
About the Author
Previous Post
Next Post
Leave a Reply
Latest News
Stay Connected
Categories
Business Health India Politics Science Sports Technology Uncategorized World
About the Author
AF themes
Easy WordPress Websites Builder: Versatile Demos for Blogs, News, eCommerce and More – One-Click Import, No Coding! 1000+ Ready-made Templates for Stunning Newspaper, Magazine, Blog, and Publishing Websites.
Search the Archives
Access over the years of investigative journalism and breaking reports
You May Have Missed
